Table 3.
Multivariable analysis of 82 RCC patients on the selected biomarkers and overall survival.
| Parameters | OS | ||
|---|---|---|---|
| Hazard ratio | 95%CI | P | |
| CD3CT | 0.979 | 0.969–0.990 | 0.000 |
| CD4+Foxp3+CD45RO | 1.123 | 1.061–1.188 | 0.000 |
| CD8+PD- | 1.039 | 1.004–1.074 | 0.027 |
Multivariable analysis of 82 RCC patients on the selected biomarkers and overall survival.
| Parameters | OS | ||
|---|---|---|---|
| Hazard ratio | 95%CI | P | |
| CD3CT | 0.979 | 0.969–0.990 | 0.000 |
| CD4+Foxp3+CD45RO | 1.123 | 1.061–1.188 | 0.000 |
| CD8+PD- | 1.039 | 1.004–1.074 | 0.027 |